NCT01816542

Brief Summary

The purpose of the study is to determine if any of Mother's Choice' all-natural personal-care products cause either irritation or allergic reaction when applied to both normal or sensitive skin. Each product will be tested on the skin using patch tests.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 22, 2013

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2013

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2013

Completed
Last Updated

March 22, 2013

Status Verified

March 1, 2013

Enrollment Period

2 months

First QC Date

February 12, 2013

Last Update Submit

March 19, 2013

Conditions

Keywords

patch-testingpersonal-carecosmeticdermatitisallergysensitive skin

Outcome Measures

Primary Outcomes (1)

  • Number of participants with positive reactions, number of positive reactions.

    Erythema, edema, blisters, pustules or erosions on the skin in the patch area will be considered a positive response. If the skin is normal after the patch removal, it means that contact with the material do not cause allergy or irritation.

    One week

Secondary Outcomes (1)

  • Number of irritant versus allergic reactions, as determined by confocal microscopy.

    On the spot

Study Arms (1)

patch tests on healthy skin

OTHER
Other: patch tests on healthy skin

Interventions

Patches will be placed on healthy skin.

patch tests on healthy skin

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Healthy adults

You may not qualify if:

  • Pregnant subjects
  • Subjects with an allergy or a skin disease which interferes with the proper results of the tests.
  • Subjects who are taking medications which can interfere with the proper results of the tests. For example: systemic corticosteroids, topical steroids applied to the test area.
  • Subjects with sun or phototherapy induced tanning at the test area.
  • Subject who had been participating in allergy tests within eight weeks prior to the present tests.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Dermatology, Hadassah University Hospital

Jerusalem, 91120, Israel

Location

Related Publications (2)

  • Mahmood T, Akhtar N. Short term study of human skin irritation by single application closed patch test: assessment of four multiple emulsion formulations loaded with botanical extracts. Cutan Ocul Toxicol. 2013 Mar;32(1):35-40. doi: 10.3109/15569527.2012.700472. Epub 2012 Jul 5.

    PMID: 22765292BACKGROUND
  • Davies RF, Johnston GA. New and emerging cosmetic allergens. Clin Dermatol. 2011 May-Jun;29(3):311-5. doi: 10.1016/j.clindermatol.2010.11.010.

    PMID: 21496740BACKGROUND

MeSH Terms

Conditions

Plaque, AmyloidDermatitisHypersensitivityEczema

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSkin DiseasesSkin and Connective Tissue DiseasesImmune System DiseasesSkin Diseases, Eczematous

Study Officials

  • Arieh Ingber, MD Prof.

    Hadassah University Hospital, Department of Dermatology

    PRINCIPAL INVESTIGATOR
  • Liran Horev, MD

    Hadassah University Hospital, Department of Dermatology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tova Silberstein, Dr.

CONTACT

Liran Horev, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2013

First Posted

March 22, 2013

Study Start

June 1, 2013

Primary Completion

August 1, 2013

Study Completion

September 1, 2013

Last Updated

March 22, 2013

Record last verified: 2013-03

Locations